On A Roll? EU Could Follow US, China & Japan In Approving Remimazolam

 
• By Neena Brizmohun

Paion’s novel sedation drug, remimazolam, was approved in the US, China, and Japan this year and now the European Medicines Agency is set to decide whether it should be authorized for use across the EU.

Four darts arrows hitting in the target center dartboard. Success business goal concept
EU approval would mark the fourth major market in which remimazolam is approved • Source: Shutterstock

More from Europe

More from Geography